EuroEyes International Eye Clinic Limited ( (HK:1846) ) just unveiled an announcement.
EuroEyes International Eye Clinic Limited has announced a board meeting scheduled for March 31, 2025, to review and approve the company’s annual results for the year ending December 31, 2024. The meeting will also consider the recommendation for a final dividend, which could impact shareholder returns and reflect the company’s financial health and strategic direction.
More about EuroEyes International Eye Clinic Limited
EuroEyes International Eye Clinic Limited operates in the healthcare industry, specializing in eye care services. The company focuses on providing advanced eye treatment solutions, including laser eye surgery and refractive lens exchange, catering to a diverse market seeking vision correction.
YTD Price Performance: -16.96%
Average Trading Volume: 182,329
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$1.05B
See more data about 1846 stock on TipRanks’ Stock Analysis page.